Ryan Reed to Compete for GMS Racing at Darlington Raceway

Ryan Reed will pilot the No. 24 Tandem Diabetes Care Chevrolet Silverado at Darlington Raceway this Friday reports GMS Racing officials.

Ryan Reed said, “I’m so excited and I can’t thank Chevy and everyone at GMS, Mike (Beam) and Maury (Gallagher), enough for the opportunity.” He added, “It is awesome to see a new partner come into the sport with Tandem Diabetes Care. I use their t:slim X2 insulin pump to help manage my type 1 diabetes and their advanced Control-IQ technology has improved my health overall. It’s incredible to be able to represent them on the track and have my daily life changed by their product.”

A new partner in NASCAR, Tandem Diabetes Care is dedicated to making the lives of people with diabetes better through relentless innovation and revolutionary customer experience.

“We are thrilled that Ryan (Reed) is experiencing the benefits of the t:slim X2 pump with Control-IQ technology, and couldn’t be more excited to support him in following his passion,” said John Sheridan, President and CEO, Tandem Diabetes Care. “We’re constantly hearing from customers about how our technology is changing lives and we believe that Ryan getting behind the wheel this weekend is yet another example of these positive outcomes.”

“We’re very grateful to have talented drivers like Ryan (Reed) to be able to step up and compete for us,” said Mike Beam, President of GMS Racing. “We’re thankful for him and his partner Tandem Diabetes Care for coming on board with us for Darlington.”

The No. 24 Tandem Diabetes Care Chevrolet Silverado will make it’s on-track debut in the LIftKits4Less.com 200 at Darlington Raceway on Friday, May 7. The race will be broadcast live on FS1 and MRN.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version